SPATA3 Antikörper (C-Term)
Kurzübersicht für SPATA3 Antikörper (C-Term) (ABIN1450070)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- 17 amino acid synthetic peptide near the carboxy terminus of Human SPATA3
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SPATA3 (Spermatogenesis Associated 3 (SPATA3))
-
Andere Bezeichnung
- SPATA3
-
Hintergrund
- The testis and spermatogenesis cell apoptosis related gene 1 (TSARG1) protein, also known as SPATA3, is highly expressed in testis, and to a lower extent in other tissues. SPATA3 contains a highly conserved J domain, which is present in all DnaJ-like proteins, and is thus a novel member of the HSP40 protein family. SPATA3 is thought to be involved in apoptosis of spermatogenic cells.Synonyms: Spermatogenesis associated protein 3, TSARG1, testis and spermatogenesis cell apoptosis related gene 1
-
Gen-ID
- 130560
-
NCBI Accession
- NP_620712
Target
-